Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 421, 678 (13 February 2003) | doi:10.1038/421678b
Open Innovation Challenges
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
-
Methods to Analyze Consumer Emotions
The Seeker is looking for methods to analyze consumer emotions. This Challenge requires only a writ...
- More Challenges
- Powered by:
nature jobs
Regional Sales Manager- Genrric Division (Copporate Office)
- Rhydburg Pharmaceuticals
- Selaqui-Dehradun India
Manager Scientific Writing
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
Cancer fears cast doubts on future of gene therapy
Erika Check
A once-promising gene-therapy treatment should be used only as a last resort, advisers to the US National Institutes of Health (NIH) said this week.Members of the NIH's Recombinant DNA Advisory Committee, meeting in Bethesda, Maryland, on 10 February, said that patients suffering from severe combined immunodeficiency disease (SCID) should be treated by gene therapy only if they fail to respond to all other treatments.
To read this story in full you will need to login or make a payment (see right).
